50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   271.59 (-2.98%)
AAPL   142.69 (-4.77%)
MSFT   236.09 (-2.07%)
META   137.43 (-2.95%)
GOOGL   96.60 (-3.45%)
AMZN   114.90 (-2.64%)
TSLA   270.81 (-5.91%)
NVDA   121.56 (-4.55%)
NIO   15.66 (-9.64%)
BABA   78.58 (-2.98%)
AMD   64.11 (-6.22%)
T   15.54 (-1.83%)
MU   50.05 (-1.86%)
CGC   2.84 (-6.58%)
F   11.52 (-5.42%)
GE   62.49 (-3.06%)
DIS   97.57 (-1.84%)
AMC   7.22 (-5.87%)
PYPL   89.53 (-1.74%)
PFE   44.44 (+0.02%)
NFLX   241.74 (-1.41%)
QQQ   271.59 (-2.98%)
AAPL   142.69 (-4.77%)
MSFT   236.09 (-2.07%)
META   137.43 (-2.95%)
GOOGL   96.60 (-3.45%)
AMZN   114.90 (-2.64%)
TSLA   270.81 (-5.91%)
NVDA   121.56 (-4.55%)
NIO   15.66 (-9.64%)
BABA   78.58 (-2.98%)
AMD   64.11 (-6.22%)
T   15.54 (-1.83%)
MU   50.05 (-1.86%)
CGC   2.84 (-6.58%)
F   11.52 (-5.42%)
GE   62.49 (-3.06%)
DIS   97.57 (-1.84%)
AMC   7.22 (-5.87%)
PYPL   89.53 (-1.74%)
PFE   44.44 (+0.02%)
NFLX   241.74 (-1.41%)
QQQ   271.59 (-2.98%)
AAPL   142.69 (-4.77%)
MSFT   236.09 (-2.07%)
META   137.43 (-2.95%)
GOOGL   96.60 (-3.45%)
AMZN   114.90 (-2.64%)
TSLA   270.81 (-5.91%)
NVDA   121.56 (-4.55%)
NIO   15.66 (-9.64%)
BABA   78.58 (-2.98%)
AMD   64.11 (-6.22%)
T   15.54 (-1.83%)
MU   50.05 (-1.86%)
CGC   2.84 (-6.58%)
F   11.52 (-5.42%)
GE   62.49 (-3.06%)
DIS   97.57 (-1.84%)
AMC   7.22 (-5.87%)
PYPL   89.53 (-1.74%)
PFE   44.44 (+0.02%)
NFLX   241.74 (-1.41%)
QQQ   271.59 (-2.98%)
AAPL   142.69 (-4.77%)
MSFT   236.09 (-2.07%)
META   137.43 (-2.95%)
GOOGL   96.60 (-3.45%)
AMZN   114.90 (-2.64%)
TSLA   270.81 (-5.91%)
NVDA   121.56 (-4.55%)
NIO   15.66 (-9.64%)
BABA   78.58 (-2.98%)
AMD   64.11 (-6.22%)
T   15.54 (-1.83%)
MU   50.05 (-1.86%)
CGC   2.84 (-6.58%)
F   11.52 (-5.42%)
GE   62.49 (-3.06%)
DIS   97.57 (-1.84%)
AMC   7.22 (-5.87%)
PYPL   89.53 (-1.74%)
PFE   44.44 (+0.02%)
NFLX   241.74 (-1.41%)
NASDAQ:IMAC

IMAC - IMAC Stock Forecast, Price & News

$0.40
+0.01 (+2.58%)
(As of 09/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.38
$0.42
50-Day Range
$0.38
$1.01
52-Week Range
$0.75
$1.65
Volume
146,026 shs
Average Volume
708,132 shs
Market Capitalization
$10.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50

IMAC MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
1,281.9% Upside
$5.50 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.08mentions of IMAC in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.34) to ($0.32) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.21 out of 5 stars

Medical Sector

1075th out of 1,096 stocks

Specialty Outpatient Clinics, Not Elsewhere Classified Industry

3rd out of 3 stocks

IMAC stock logo

About IMAC (NASDAQ:IMAC) Stock

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.

Receive IMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC Stock News Headlines

IMAC Holdings Inc
See More Headlines
Receive IMAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMAC and its competitors with MarketBeat's FREE daily newsletter.

IMAC Company Calendar

Last Earnings
4/14/2022
Today
9/29/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Specialty outpatient clinics, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IMAC
Fax
N/A
Employees
106
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.50
High Stock Price Forecast
$5.50
Low Stock Price Forecast
$5.50
Forecasted Upside/Downside
+1,281.9%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-10,540,000.00
Pretax Margin
-75.40%

Debt

Sales & Book Value

Annual Sales
$14.39 million
Book Value
$0.69 per share

Miscellaneous

Free Float
23,837,000
Market Cap
$10.54 million
Optionable
Not Optionable
Beta
-0.88

Key Executives

  • Mr. Jeffrey S. Ervin M.B.A. (Age 44)
    Chairman & CEO
    Comp: $377.69k
  • Dr. Matthew C. WallisDr. Matthew C. Wallis (Age 48)
    Pres & Exec. Director
    Comp: $289.83k
  • Ms. Sheri F. Gardzina CPA (Age 53)
    CPA, CFO & Corp. Sec.
    Comp: $254.82k
  • Dr. Ben Lerner (Age 55)
    Chief Operating Officer
  • Mr. Frank DeVito III
    Director of Sales
  • Ms. Norleidy Hernandez
    HR Director
  • Mr. Sandy Miller
    Chief of Staff













IMAC Stock - Frequently Asked Questions

What is IMAC's stock price forecast for 2022?

0 brokers have issued 1-year price targets for IMAC's shares. Their IMAC share price forecasts range from $5.50 to $5.50. On average, they expect the company's stock price to reach $5.50 in the next year. This suggests a possible upside of 1,281.9% from the stock's current price.
View analysts price targets for IMAC
or view top-rated stocks among Wall Street analysts.

How have IMAC shares performed in 2022?

IMAC's stock was trading at $1.14 at the start of the year. Since then, IMAC stock has decreased by 65.1% and is now trading at $0.3980.
View the best growth stocks for 2022 here
.

How were IMAC's earnings last quarter?

IMAC Holdings, Inc. (NASDAQ:IMAC) released its quarterly earnings data on Thursday, April, 14th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.09) by $0.03. IMAC had a negative trailing twelve-month return on equity of 52.17% and a negative net margin of 75.40%.

What other stocks do shareholders of IMAC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IMAC investors own include VBI Vaccines (VBIV), Biocept (BIOC), Energy Transfer (ET), iBio (IBIO), McEwen Mining (MUX), OPKO Health (OPK), Advanced Micro Devices (AMD), Amarin (AMRN), Aytu BioPharma (AYTU) and Bionano Genomics (BNGO).

When did IMAC IPO?

(IMAC) raised $4 million in an initial public offering (IPO) on the week of February 11th 2019. The company issued 900,000 shares at a price of $5.00 per share. Dawson James Securities and Cuttone served as the underwriters for the IPO.

What is IMAC's stock symbol?

IMAC trades on the NASDAQ under the ticker symbol "IMAC."

How do I buy shares of IMAC?

Shares of IMAC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IMAC's stock price today?

One share of IMAC stock can currently be purchased for approximately $0.40.

How much money does IMAC make?

IMAC (NASDAQ:IMAC) has a market capitalization of $10.54 million and generates $14.39 million in revenue each year.

How many employees does IMAC have?

The company employs 106 workers across the globe.

How can I contact IMAC?

IMAC's mailing address is 1605 WESTGATE CIRCLE, BRENTWOOD TN, 37027. The official website for the company is www.imacregeneration.com. The company can be reached via phone at (844) 266-4622 or via email at brets@coreir.com.

This page (NASDAQ:IMAC) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.